Analysis of functional regions of YPM, a superantigen derived from gram- negative bacteria

European Journal of Biochemistry

Volumn 263, Issue 2, 1999, Pages 326-337

  Ito, Yasuhiko ^a   Seprényi, György ^a   Abe, Jun ^a   Kohsaka, Takao ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Binding sites; HLA DR; Mutagenesis; Superantigen; TCR

Indexed keywords

CYSTEINE; ENTEROTOXIN; HLA DR ANTIGEN; SUPERANTIGEN; SUPERANTIGEN YPM; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BINDING COMPETITION; CELL PROLIFERATION; CONTROLLED STUDY; MOLECULAR INTERACTION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FOLDING; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS; YERSINIA PSEUDOTUBERCULOSIS;

AMINO ACID SEQUENCE; AMINO ACIDS; BACTERIAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAM-NEGATIVE BACTERIA; HLA-DR ANTIGENS; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS; POINT MUTATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SUPERANTIGENS;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; YERSINIA PSEUDOTUBERCULOSIS;

EID: 0033565354     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00472.x     Document Type: Article

References (53)

1. 1. Herman, A., Kappler, J.W., Marack, P. & Pullen, A.M. (1991) Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9, 745-772.
2. 2. Scholl, P.R., Diez, A., Karr, R., Sekaly, R.P., Trowsdale, J. & Geha, R.S. (1990) Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J. Immunol. 144, 226-230.
3. 3. Kotzin, B.L., Leung, D.Y.M., Kappler, J. & Marrack, P. (1993) Superantigens and their potential role in human disease. Adv. Immunol. 54, 99-166.
4. 4. Konishi, N., Baba, K., Abe, J., Maruko, T., Waki, K., Takeda, N. & Tanaka, M. (1997) A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection. Acta Paediatr. 86, 661-664.
5. 5. Marrack, P. & Kappler, J. (1990) The staphylococcal enterotoxins and their relatives. Science 248, 705-711.
6. 6. Ren, K., Bannan, J.D., Pancholi, V., Cheung, A.L., Robbins, J.C., Fischetti, V.A. & Zabriskie, J.B. (1994) Characterization and biological properties of a new staphylococcal exotoxin. J. Exp. Med. 180, 1675-1683.
7. 7. Su, Y.-C. & Wong, A.C.L. (1995) Identification and purification of a new staphylococcal enterotoxin, H. Appl. Environ. Microbiol. 61, 1438-1443.
8. 8. Munson, S.H., Tremaine, M.T., Betley, M.J. & Welch, R.A. (1998) Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect. Immun. 66, 3337-3348.
9. 9. Swaminathan, S., Furey, W., Pletcher, J. & Sax, M. (1992) Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359, 801-806.
10. 10. Prasad, G.S., Earhart, C.A., Murray, D.L., Novick, R.P., Schlievert, P.M. & Ohlendorf, D.H. (1993) Structure of toxic shock syndrome toxin 1. Biochemistry 32, 13761-13766.
11. 11. Acharya, K.R., Passalacqua, E.F., Jones, E.Y., Harlos, K., Stuart, D.I., Brehm, R.D. & Tranter, H.S. (1994) Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1. Nature 367, 94-97.
12. 12. Schad, E.M., Zaitseva, I., Zaitsev, V.N., Dohlsten, M., Kalland, T., Schlievert, P.M., Ohlendorf, D.H. & Svensson, L.A. (1995) Crystal strucure of the superantigen staphylococcal enterotoxin type A. EMBO J. 14, 3292-3301.
13. 13. Papageorgiou, A.C., Acharya, K.R., Shapiro, R., Passalacqua, E.F., Brehm, R.D. & Tranter, H.S. (1995) Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 3, 769-779.
14. 14. Swaminathan, S., Furey, W., Pletcher, J. & Sax, M. (1995) Residues defining Vβ specificity in staphylococcal entertoxins. Nat. Struct. Biol. 2, 680-686.
15. 2+-mediated homodimerization. EMBO J. 15, 6832-6840.
16. 2+ at 2.7 Å resolution. J. Biol. Chem. 271, 32212-32216.
17. 17. Roussel, A., Anderson, B.F., Baker, H.M., Fraser, J.D. & Baker, E.N. (1997) Crystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II molecules. Nat. Struct. Biol. 4, 635-643.
18. 18. Jardetzky, T.S., Brown, J.H., Gorga, J.C., Stern, L.J., Urban, R.G., Chi, Y.-I., Stauffacher, C., Strominger, J.L. & Wiley, D.C. (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711-718.
19. 19. Kim, J., Urban, R.G., Strominger, J.L. & Wiley, D.C. (1994) Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DRI. Science 266, 1870-1874.
20. 20. Fields, B.A., Malchiodi, E.L., Ysern, H., Li, X., Stauffacher, C.V., Schlievert, P.M., Karjalainen, K. & Mariuzza, R.A. (1996) Crystal structure of a T-cell receptor β-chain complexed with a superantigen. Nature 384, 188-192.
21. 21. Kappler, J.W., Herman, A., Clements, J. & Marrack, P. (1992) Mutations defining functional regions of the superantigen staphylococcal enterotoxin B. J. Exp. Med. 175, 387-396.
22. 22. Hurley, J.M., Shimonkevitz, R., Hanagan, A., Enney, K., Boen, E., Malmstrom, S., Kotzin, B.L. & Matsumura, M. (1995) Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1. J. Exp. Med. 181, 2229-2235.
23. 23. Fraser, J.D., Urban, R.G., Strominger, J.L. & Robinson, H. (1992) Zinc regulates the function of two superantigens. Proc. Natl Acad. Sci. USA 89, 5507-5511.
24. 24. Hudson, K.R., Tiedemann, R.E., Urban, R.G., Lowe, S.C., Strominger, J.L. & Fraser, J.D. (1995) Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J. Exp. Med. 182, 711-720.
25. 25. Li, P.-L., Tiedemann, R.E., Moffat, S.L. & Fraser, J.D. (1997) The superantigen streptococcal pyrogenic exotoxin C (SPE-C) exhibits a novel mode of action. J. Exp. Med. 186, 375-383.
26. 26. AI-Daccak, R., Mehindate, K., Damdoumi, F., Etongué-Mayer, P., Nilsson, H., Antonsson, P., Sundström, M., Dohlsten, M., Sékaly, R.-P. & Mourad, W. (1998) Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors. J. Immunol. 16, 225-232.
27. 27. Abrahmsén, L., Dohlsten, M., Segrén, S., Björk, P., Jonsson, E. & Kalland, T. (1995) Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J. 14, 2978-2986.
28. 28. Thibodeau, J., Dohlsten, M., Cloutier, I., Lavoie, P.M., Bjork, P., Michel, F., Léveillé, C., Mourad, W., Kalland, T. & Sékaly, R.-P. (1997) Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR α-chain. J. Immunol. 158, 3698-3704.
29. 29. Hargreaves, R.E.G., Brehm, R.D., Tranter, H., Warrens, A.N., Lombardi, G. & Lechler, R.I. (1995) Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2. Eur. J. Immunol. 25, 3437-3444.
30. 30. Dowd, J.E., Karr, R.W. & Karp, D.R. (1996) Functional activity of staphylococcal enterotoxin A requires interactions with both the alpha and beta chains of HLA-DR. Mol. Immunol. 33, 1267-1274.
31. 31. Newton, D.W., Dohlsten, M., Olsson, C., Segrén, S., Lundin, K.E.A., Lando, P.A., Kalland, T. & Kotb, M. (1996) Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vβ specificity. J. Immunol. 157, 3988-3994.
32. 32. Leino, R., Mäkelä, A.-L., Tiilikainen, A. & Toivanen, A. (1980) Yersinia arthritis in children. Scand. J. Rheumatol. 9, 245-249.
33. 33. Pennec, Y., Mottier, D., Youinou, P. & Le Menn, G. (1981) Reiter's disease and Yersina pseudotuberculosis infection. J. Rheumatol. 8, 868-869.
34. 34. Krober, M.S., Bass, J.W. & Barcia, P.J. (1983) Scarlatiniform rash and pleural effusion in a patient with Yersinia pseudotuberculosis infection. J. Pediatr. 102, 879-881.
35. 35. Takeda, N., Usami, I., Fujita, A., Baba, K. & Tanaka, M. (1991) Renal complications of Yersinia pseudotuberculosis infection in children. Contrib. Microbiol. Immunol. 12, 301-306.
36. 36. Abe, J., Takeda, T., Watanabe, Y., Nakao, H., Kobayashi, N., Leung, D.Y.M. & Kohsaka, T. (1993) Evidence for superantigen production by Yersinia pseudotuberculosis. J. Immunol. 151, 4183-4188.
37. 37. Miyoshi-Akiyama, T., Imanishi, K. & Uchiyama, T. (1993) Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells. Infect. Immun. 61, 3922-3927.
38. 38. Uchiyama, T., Miyoshi-Akiyama, T., Kato, H., Fujimaki, W., Imanishi, K. & Yan, X.-J. (1993) Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J. Immunol. 151, 4407-4413.
39. 39. Yoshino, K., Abe, J., Murata, H., Takao, T., Kohsaka, T., Shimonishi, Y. & Takeda, T. (1994) Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis. FEBS Lett. 356, 141-144.
40. 40. Ito, Y., Abe, J., Yoshino, K., Takeda, T. & Kohsaka, T. (1995) Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein. J. Immunol. 154, 5896-5906.
41. 41. Miyoshi-Akiyama, T., Abe, A., Kato, H., Kawahara, K., Narimatsu, H. & Uchiyama, T. (1995) DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM. J. Immunol. 154, 5228-5234.
42. 42. Yoshino, K., Takao, T., Ishibashi, M., Samejima, Y., Shimonishi, Y. & Takeda, T. (1996) Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides. FEBS Lett. 390, 196-198.
43. 43. Ramamurthy, T., Yoshino, K., Abe, J., Ikeda, N. & Takeda, T. (1997) Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen. FEBS Lett. 413, 174-176.
44. 44. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
45. 45. Drenth, J., Jansonius, J.N., Koekoek, R., Swen, H.M. & Wolthers, B.G. (1968) Structure of papain. Nature 218, 929-932.
46. 46. Marsh, S.G.E. & Bodmer, J.G. (1989) HLA-DR and -DQ epitopes and monoclonal antibody specificity. Immunol. Today 10, 305-312.
47. 47. Kozono, H., Parker, D., White, J., Marrack, P. & Kappler, J. (1995) Multiple binding sites for bacterial superantigens on soluble class II MHC molecules. Immunity 3, 187-196.
48. 48. Kyte, J. & Doolittle, R.F. (1982) A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132.
49. 49. Ota, M. & Nishikawa, K. (1997) Assessment of pseudo-energy potentials by the best-five test: a new use of the three-dimensional profiles of proteins. Protein Eng. 10, 339-351.
50. 50. Leder, L., Llera, A., Lavoie, P.M., Lebedeva, M.I., Li, H., Sékaly, R.-P., Bohach, G.A., Gahr, P.J., Schlievert, P.M., Karjalainen, K. & Mariuzza, R.A. (1998) A mutational analysis of the binding of staphylococcal enterotoxins B and C3 to the T cell receptor β chain and major histocompatibility complex class II. J. Exp. Med. 187, 823-833.
51. 51. Liao, L., Marinescu, A., Molano, A., Ciurli, C., Sekaly, R.-P., Fraser, J.D., Popowicz, A. & Posnett, D.N. (1996) TCR binding differs for a bacterial superantigen (SEE) and a viral superantigen (Mtv-9). J. Exp. Med. 184, 1471-1482.
52. 52. Mollick, J.A., McMasters, R.L., Grossman, D. & Rich, R.R. (1993) Localization of a site on bacterial superantigens that determines T cell receptor β chain specificity. J. Exp. Med. 177, 283-293.
53. 53. Lamphear, J.G., Mollick, J.A., Reda, K.B. & Rich, R.R. (1996) Residues near the amino and carboxyl termini of staphylococcal enterotoxin E independently mediate TCR Vβ-specific interactions. J. Immunol. 156, 2178-2185.